Trials / Completed
CompletedNCT02933658
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
A non-randomized, two-arm, single-sequence, crossover, open label, multiple oral dosing clinical trial to evaluate the safety and the pharmacokinetic drug-drug interaction of Telmisartan/Amlodipine and Rosuvastatin in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan | |
| DRUG | Amlodipine | |
| DRUG | Rosuvastatin |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2015-11-01
- First posted
- 2016-10-14
- Last updated
- 2016-10-14
Source: ClinicalTrials.gov record NCT02933658. Inclusion in this directory is not an endorsement.